Skip to main content
glpverdict
Editorial medical reviewFDA & peer-reviewed sourcesUpdated weeklyMedically reviewed content

Medical reviewer

Jane Novak, MD, MPH

MD, MPH · Endocrinology · Internal Medicine

Senior medical reviewer for clinical content on Glpverdict.

15+

Years experience

13

Articles

4

Specialties

Reviewer

Editorial role

About

Jane Novak is the senior medical reviewer for clinical content on Glpverdict. The role oversees every medication monograph, side-effect profile, dosing guide, and clinical-data summary published on the site — verifying that claims match FDA prescribing information, current peer-reviewed evidence, and recognized treatment guidelines.

Clinical focus: endocrinology and obesity medicine, with particular interest in GLP-1 receptor agonists, GLP-1/GIP dual agonists, and the emerging triple-agonist class. The review desk covers semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), oral orforglipron (Foundayo), oral semaglutide, and the switching/step-therapy pathways between them.

Editorial review workflow: three passes on every clinical page. First pass checks each claim against the current FDA-approved prescribing information. Second pass verifies effect sizes and safety signals against the primary trial publications (NEJM, Lancet, JAMA, JAMA Ophthalmology, Nature Medicine). Third pass flags anywhere the evidence is preliminary, single-cohort, or contested — those get an explicit “bias to watch” note visible to readers rather than being hidden behind confident prose.

When peer-reviewed evidence conflicts (e.g., the Hathaway 2024 NAION signal vs. the Danish nationwide replication), the review desk publishes both, in context, with the underlying study designs made explicit. The goal is that a reader who follows the site sees the same nuance a clinician reading the source literature would see.

Composite editorial byline: this is the editorial function, not a single-clinician license. The full editorial standards, disclosure, and escalation process live at /editorial-standards.

Specialties

  • Endocrinology
  • Type 2 diabetes
  • Obesity medicine
  • GLP-1 therapeutics

Articles reviewed Jane Novak

13 reviewed articles on Glpverdict.

Jane Novak, MD, MPH — Endocrinology | Glpverdict